Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

Author: Birkeland Einar   Busch Christian   Berge Elisabet   Geisler Jürgen   Jönsson Göran   Lillehaug Johan   Knappskog Stian   Lønning Per  

Publisher: Springer Publishing Company

ISSN: 0262-0898

Source: Clinical and Experimental Metastasis, Vol.30, Iss.7, 2013-10, pp. : 867-876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content